Independents, Community Pharmacies Can Get Involved in Tobacco Cessation Programs
July 19th 2024Having the authority to prescribe nicotine replacement therapies does not mean that pharmacists are getting involved in these programs, so ongoing research is investigating how to create sustainable models with greater pharmacist involvement.
Public Health Matters Video: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
July 18th 2024Tune into this episode of “Public Health Matters” to hear how Walmart is leveraging its network to provide HIV care and specialty pharmacy services and how integrating community pharmacy outreach is significant for patients.
Expert: Availability of OTC Naloxone in Stores, Pharmacies Will Lead to Greater Uptake
July 16th 2024Allison Burns discusses how pharmacists should prepare and educate themselves regarding OTC naloxone, and the steps that can be taken in stores and pharmacies to ensure OTC naloxone is visible and available.
Impact of Emerging Therapies on Outcomes for EGFR-Mutated NSCLC
July 12th 2024Alan Chin, PharmD, BCOP, examines the PALOMA-3 trial's influence on the treatment of EGFR-mutated metastatic NSCLC and explores the evolving role of antibody-drug conjugates (ADCs) in the therapeutic landscape of EGFR-mutated NSCLC.
Role of the Pharmacist in Vaccinating Against RSV
July 9th 2024Carrie Koenigsfeld, PharmD, FAPhA, shares strategies that pharmacists can use to effectively tackle vaccine hesitancy, particularly concerning newer vaccines such as the RSV vaccine, through building trust with patients to encourage informed decision-making.
RSV Vaccine Administration Timing and Errors
July 9th 2024A medical expert examines the ideal timing for administering RSV vaccines to adults over 60 or pregnant women, emphasizing the importance of proper timing for a single-dose vaccine and outlining the necessary steps to be taken if a pregnant woman inadvertently receives an adjuvanted RSV vaccine.
Expert Insights on Managing Amivantamab Infusion Reactions, Dosing, and Medication
July 5th 2024A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.
Common Adverse Reactions to EGFR Therapy
July 5th 2024Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.
RSV Vaccine Efficacy in Pregnancy
July 2nd 2024Carrie Koenigsfeld, PharmD, FAPhA, highlights the main findings from the MATISSE trial, which evaluated the safety and efficacy of a non-adjuvanted RSV vaccine administered to pregnant women, presenting data that suggests the vaccine's effectiveness in preventing severe RSV in infants and discussing the observed adverse events in both mothers and infants.
Exploring Key Insights from the PAPILLON Trial
June 28th 2024A clinical pharmacy specialist examines treatment strategies for EGFR exon 20 insertion mutations, referencing data from the PAPILLON trial, and addresses the challenges associated with managing brain metastases in this patient population.
Expert: Having Conversations and Practicing Cultural Competency With LGBTQIA+ Patients
June 27th 2024HOPA’s DEI Advisory Board Chair discusses how creating safe environments, using correct pronouns, and being willing to talk about patients’ mental and physical needs are significant when providing care to LGBTQIA+ patients.